CYP4V2 and Bietti crystalline dystrophy: Thus, some of the opportunities in studies of CYP4V2 are to ascertain the exact molecular mechanism(s) underlying the BCD ocular phenotype and to develop gene therapy or pharmacologic treatments for this currently incurable disease.